Lubiprostone 8mcg Capsules

Manufacturer PAR Active Ingredient Lubiprostone(loo bi PROS tone) Pronunciation loo bi PROS tone
It is used to treat constipation.It is used to treat irritable bowel syndrome with constipation (IBS-C).
🏷️
Drug Class
Chloride Channel Activator; Laxative
🧬
Pharmacologic Class
Bicyclic Fatty Acid
🀰
Pregnancy Category
Category C
βœ…
FDA Approved
Jan 2006
βš–οΈ
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

Lubiprostone is a medication used to treat a type of constipation called Irritable Bowel Syndrome with Constipation (IBS-C). It works by increasing the amount of fluid in your intestines, which helps to soften your stool and make it easier to have a bowel movement.
πŸ“‹

How to Use This Medicine

Taking Your Medication Correctly

To ensure you get the most benefit from your medication, follow these steps:

Take your medication exactly as directed by your doctor.
Read all the information provided with your medication and follow the instructions carefully.
Take your medication with food and a full glass of water.
Swallow the medication whole; do not chew, break, or crush it.

Storing and Disposing of Your Medication

To maintain the effectiveness and safety of your medication:

Store it at room temperature, protected from light.
Keep it in a dry place, avoiding storage in a bathroom.
Keep all medications in a safe location, out of the reach of children and pets.
Dispose of unused or expired medications properly. Do not flush them down the toilet or pour them down the drain unless instructed to do so by your pharmacist.
Check with your pharmacist for guidance on the best way to dispose of medications. You may also have access to drug take-back programs in your area.

What to Do If You Miss a Dose

If you miss a dose of your medication:

Take it as soon as you remember.
If it is close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule.
Do not take two doses at the same time or take extra doses to make up for a missed dose.
πŸ’‘

Lifestyle & Tips

  • Take the capsule whole with food and water to help reduce nausea.
  • Maintain adequate hydration by drinking plenty of fluids throughout the day.
  • Consider a diet rich in fiber, unless advised otherwise by your doctor.
  • Engage in regular physical activity, which can help promote bowel regularity.
πŸ’Š

Available Forms & Alternatives

Dosing & Administration

πŸ‘¨β€βš•οΈ

Adult Dosing

Standard Dose: 8 mcg orally twice daily
Dose Range: 8 - 8 mg

Condition-Specific Dosing:

Irritable Bowel Syndrome with Constipation (IBS-C): 8 mcg orally twice daily
πŸ‘Ά

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established (Lubiprostone 24 mcg is approved for Chronic Idiopathic Constipation in children 6-17 years, but 8 mcg is not)
Adolescent: Not established (Lubiprostone 24 mcg is approved for Chronic Idiopathic Constipation in children 6-17 years, but 8 mcg is not)
βš•οΈ

Dose Adjustments

Renal Impairment:

Mild: No adjustment needed
Moderate: No adjustment needed
Severe: No adjustment needed
Dialysis: No specific recommendations; minimal systemic exposure

Hepatic Impairment:

Mild: No adjustment needed
Moderate: For IBS-C (8 mcg BID), consider 8 mcg orally once daily
Severe: For IBS-C (8 mcg BID), consider 8 mcg orally every other day

Pharmacology

πŸ”¬

Mechanism of Action

Lubiprostone is a bicyclic fatty acid that acts locally in the gastrointestinal tract to activate ClC-2 chloride channels on the apical membrane of gastrointestinal epithelial cells. This activation increases intestinal fluid secretion, which in turn softens the stool, increases bowel movement frequency, and improves symptoms associated with chronic idiopathic constipation and irritable bowel syndrome with constipation.
πŸ“Š

Pharmacokinetics

Absorption:

Bioavailability: Not precisely determined due to extensive first-pass metabolism
Tmax: Approximately 1.14 hours
FoodEffect: Taking with food may decrease peak concentration (Cmax) and delay time to peak concentration (Tmax), but does not affect overall exposure (AUC).

Distribution:

Vd: Not determined
ProteinBinding: Approximately 94% (parent drug)
CnssPenetration: Limited

Elimination:

HalfLife: Approximately 0.9 to 1.4 hours (parent drug)
Clearance: Not determined
ExcretionRoute: Primarily via feces (approximately 60% as metabolites), minimal renal excretion (<1% as parent drug)
Unchanged: <1%
⏱️

Pharmacodynamics

OnsetOfAction: Within 24 hours for initial bowel movement in some patients
PeakEffect: Not directly applicable for a laxative effect, but consistent effects seen within the first week of treatment.
DurationOfAction: Effects persist with continued dosing; short half-life requires twice-daily dosing.

Safety & Warnings

⚠️

Side Effects

Urgent Side Effects: Seek Medical Attention Immediately
While rare, this medication can cause severe and potentially life-threatening side effects. If you experience any of the following symptoms, contact your doctor or seek medical help right away:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Shortness of breath
Low blood pressure, which can lead to hospitalization. You may be at higher risk if you experience diarrhea or vomiting. If you feel extremely dizzy or lightheaded, contact your doctor immediately.

Other Possible Side Effects
Like all medications, this drug can cause side effects, although many people may not experience any or may only have mild symptoms. If you are bothered by any of the following side effects or if they persist, contact your doctor or seek medical help:

Headache
Stomach pain or diarrhea
Gas
Bloating
Upset stomach

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Severe diarrhea (contact your doctor immediately)
  • Severe nausea or vomiting that prevents you from taking the medication
  • Sudden onset of difficulty breathing or shortness of breath
  • Feeling dizzy or lightheaded, or fainting (syncope)
  • Worsening abdominal pain or new symptoms of bowel obstruction
πŸ“‹

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
Certain health conditions, including:
+ Bowel blockage
+ Diarrhea

This list is not exhaustive, and it is crucial to discuss all your health problems with your doctor.

Additionally, provide your doctor and pharmacist with a comprehensive list of all the medications you are taking, including:
Prescription medications
Over-the-counter (OTC) medications
Natural products
Vitamins

It is vital to verify that it is safe to take this medication with all your other medications and health conditions. Do not initiate, stop, or modify the dosage of any medication without first consulting your doctor.
⚠️

Precautions & Cautions

It is essential to inform all of your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. If you are pregnant, planning to become pregnant, or are currently breast-feeding, be sure to discuss this with your doctor. Your doctor will need to weigh the benefits and risks of this medication for both you and your baby to determine the best course of action.
πŸ†˜

Overdose Information

Overdose Symptoms:

  • Severe diarrhea
  • Nausea
  • Vomiting
  • Abdominal discomfort

What to Do:

There is no specific antidote for lubiprostone overdose. Management should be supportive and symptomatic, focusing on fluid and electrolyte replacement if severe diarrhea occurs. Contact a poison control center (e.g., 1-800-222-1222) or seek emergency medical attention immediately.

Drug Interactions

Monitoring

πŸ”¬

Baseline Monitoring

Rule out mechanical bowel obstruction

Rationale: Lubiprostone is contraindicated in patients with known or suspected mechanical gastrointestinal obstruction.

Timing: Prior to initiation of therapy

Assess constipation history and symptoms

Rationale: To confirm diagnosis and establish baseline for treatment efficacy.

Timing: Prior to initiation of therapy

πŸ“Š

Routine Monitoring

Bowel movement frequency and consistency

Frequency: Daily or as needed

Target: Improved frequency and softer stools

Action Threshold: Lack of improvement after several weeks, or worsening constipation.

Adverse effects (e.g., nausea, diarrhea, abdominal pain, dyspnea, syncope)

Frequency: Regularly, especially during initial treatment

Target: Absence or mild, tolerable symptoms

Action Threshold: Severe or persistent symptoms warrant dose reduction or discontinuation.

πŸ‘οΈ

Symptom Monitoring

  • Severe diarrhea
  • Severe nausea or vomiting
  • Abdominal pain or cramping
  • Dyspnea (shortness of breath)
  • Syncope (fainting or dizziness)

Special Patient Groups

🀰

Pregnancy

Category C. Use only if the potential benefit justifies the potential risk to the fetus. Animal studies have shown adverse effects at high doses.

Trimester-Specific Risks:

First Trimester: Potential for developmental toxicity observed in animal studies at doses higher than human therapeutic doses.
Second Trimester: Limited human data; animal data suggest potential risks.
Third Trimester: Limited human data; animal data suggest potential risks.
🀱

Lactation

Caution advised. Lubiprostone and its active metabolite are excreted in the milk of lactating rats. It is not known whether lubiprostone is excreted in human milk. Weigh the developmental and health benefits of breastfeeding against the mother’s clinical need for lubiprostone and any potential adverse effects on the breastfed infant from lubiprostone or from the underlying maternal condition.

Infant Risk: Potential for diarrhea in breastfed infant; human data are limited.
πŸ‘Ά

Pediatric Use

The 8 mcg capsule is not approved for pediatric use. Lubiprostone 24 mcg is approved for Chronic Idiopathic Constipation (CIC) in children 6-17 years of age, but not for IBS-C. Safety and efficacy for IBS-C in pediatric patients have not been established.

πŸ‘΄

Geriatric Use

No specific dose adjustment is required based on age. However, elderly patients may be more susceptible to fluid and electrolyte imbalances due to diarrhea, and should be monitored closely.

Clinical Information

πŸ’Ž

Clinical Pearls

  • Always take lubiprostone with food and water to minimize the risk of nausea, which is a common side effect.
  • Lubiprostone is contraindicated in patients with known or suspected mechanical gastrointestinal obstruction; ensure this is ruled out before starting therapy.
  • Patients should be advised to discontinue lubiprostone and contact their healthcare provider if severe diarrhea occurs.
  • The 8 mcg dose is specifically indicated for Irritable Bowel Syndrome with Constipation (IBS-C), while higher doses (24 mcg) are used for Chronic Idiopathic Constipation (CIC) and Opioid-Induced Constipation (OIC).
  • Dyspnea (shortness of breath) and syncope (fainting) are rare but serious adverse effects that warrant immediate medical attention.
πŸ”„

Alternative Therapies

  • Linaclotide (Linzess)
  • Plecanatide (Trulance)
  • Prucalopride (Motegrity)
  • Polyethylene Glycol (PEG) 3350 (MiraLAX)
  • Fiber supplements (e.g., psyllium, methylcellulose)
  • Stool softeners (e.g., docusate sodium)
  • Osmotic laxatives (e.g., lactulose, magnesium hydroxide)
πŸ’°

Cost & Coverage

Average Cost: Varies widely; check current market data per 30 capsules
Generic Available: Yes
Insurance Coverage: Tier 2 or 3 (may require prior authorization)
πŸ“š

General Drug Facts

If your symptoms or health issues persist or worsen, it's essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so be sure to check with your pharmacist for more information. If you have any questions or concerns about this medication, don't hesitate to reach out to your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek medical attention. When seeking help, be prepared to provide details about the medication, including the amount taken and the time it happened, to facilitate prompt and effective treatment.